<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport"  maximum-scale="1.0">
<title>北京大学药学院分子与细胞药理学系</title>
<link href="../../css/css201801/base.css" type="text/css" rel="stylesheet" />
<link href="../../css/css201801/style.css" type="text/css" rel="stylesheet" />
<!--IE6透明代码-->
<!--[if IE 6]>
<script src="../../js/js201801/pngAlaph.js"></script>
<script>
DD_belatedPNG.fix('.logo, img');
</script>
<![endif]-->
</head>
<style>
.article strong{font-weight:bold;}
</style>
<body>


<div class="header">
    	<div class="top">
        	<div class="top_nav">
            	<a href="../../index.htm" class="nobg">中文</a><span>|</span>
                <a href="#">EN</a>
            </div>

            <div class="logo">
              <a href="../../index.htm" class="logo_link"><img src="../../images/images201801/logo2.png"></a>
            </div>

           <div class="search">
           		<form name="dataForm" action="/cms/search/searchResults.jsp" target="_blank" method="post" accept-charset="utf-8" onsubmit="document.charset='utf-8';">
                    <input name="siteID" value="79" type ="hidden">
                    <input class="notxt" value="站内搜索" name="query" type="text" id="keywords" onFocus="if(value==defaultValue){value='';}" onBlur="if(!value){value=defaultValue;}"
                     onclick="if(this.value=='站内搜索'){this.value='';this.form.keywords.style.color='#3c98cc'}">
                    <input class="notxt1" name="Submit" type="submit" value="" />
                </form>
       		</div>
        </div>
        <div class="nav" >
            <ul id="nav">
 <li><a href="../../index.htm">首页</a></li>
                           
                                          <li>
                                                                <a href="../../ylxjj_20180111164201885235/index.htm">系室概况</a>
                                                              </li>
                                                       <li>
                                                                    
                                     <a href="../index.htm">师资队伍</a>
                                    
                                     <div class="subNav">
                                        <dl>
                                                                                <dd>  <a href="../js_20180115155901250603/index.htm">教授</a> </dd>
                                                                                <dd>  <a href="index.htm">特聘研究员</a> </dd>
                                                                                <dd>  <a href="../fjs_20180115155901250603/index.htm">副教授</a> </dd>
                                                                                <dd>  <a href="../j_s_20180115155901250603/index.htm">讲师</a> </dd>
                                                                                <dd>  <a href="../jfry_20180115155901250603/index.htm">教辅人员</a> </dd>
                                                                                <dd>  <a href="../txjs_20180115155901250603/index.htm">退休教师</a> </dd>
                                                                                </dl>
                                     </div>
                                                              </li>
                                                       <li>
                                                                    
                                     <a href="../../rcpy_20180115155906248735/index.htm">人才培养</a>
                                    
                                     <div class="subNav">
                                        <dl>
                                                                                <dd>  <a href="../../rcpy_20180115155906248735/bks_20180115155906248735/index.htm">本科生</a> </dd>
                                                                                <dd>  <a href="../../rcpy_20180115155906248735/yjs_20180115155906248735/index.htm">研究生</a> </dd>
                                                                                </dl>
                                     </div>
                                                              </li>
                                                       <li>
                                                                    
                                     <a href="../../kxyj_20180115155913555832/index.htm">科学研究</a>
                                    
                                     <div class="subNav">
                                        <dl>
                                                                                <dd>  <a href="../../kxyj_20180115155913555832/ktz/index.htm">课题组</a> </dd>
                                                                                <dd>  <a href="../../kxyj_20180115155913555832/yjfx/index.htm">研究方向</a> </dd>
                                                                                </dl>
                                     </div>
                                                              </li>
                                                       <li>
                                                                <a href="../../zdxk/index.htm">党建工会</a>
                                                              </li>
                                                       <li>
                                                                <a href="../../zpxx_20180115155952450926/index.htm">招聘信息 </a>
                                                              </li>
                                                       <li>
                                                                <a href="../../lxfs_20180115155959563075/index.htm">系室领导</a>
                                                              </li>
                                                       <li>
                                                                    
                                     <a href="../../dbxlw/index.htm">代表论文</a>
                                    
                                     <div class="subNav">
                                        <dl>
                                                                                <dd>  <a href="../../dbxlw/2019/index.htm">2019</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2018/index.htm">2018</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2017/index.htm">2017</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2016/index.htm">2016</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2015/index.htm">2015</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2014/index.htm">2014</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2013/index.htm">2013</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2012/index.htm">2012</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2011/index.htm">2011</a> </dd>
                                                                                <dd>  <a href="../../dbxlw/2010/index.htm">2010</a> </dd>
                                                                                </dl>
                                     </div>
                                                              </li>
                                                       <li>
                                                                <a href="http://202.112.183.161/">课程建设</a>
                                                              </li>
                           <li><a href="../../gbenglish/index.htm">English</a></li>          </ul>
          <!--        下拉菜单效果 结束         -->

      </div>
</div><div class="subPage">
    <div class="con">
    	<div class="con_left">
            <div class="left_title">
                <h2><a href="#">师资队伍</a></h2>
            </div>
            <ul>
                                                <li><a href="../js_20180115155901250603/index.htm">教授</a></li>
                                                                <li class="on"><a href="index.htm">特聘研究员</a></li>
                                                                <li><a href="../fjs_20180115155901250603/index.htm">副教授</a></li>
                                                                <li><a href="../j_s_20180115155901250603/index.htm">讲师</a></li>
                                                                <li><a href="../jfry_20180115155901250603/index.htm">教辅人员</a></li>
                                                                <li><a href="../txjs_20180115155901250603/index.htm">退休教师</a></li>
                                            </ul>
              <!-- <div class="left_list_info">
            <a href=""><img src="../../images/images201801/3.png"></a>
            <a href=""><img src="../../images/images201801/3.png"></a>
          </div> -->
        </div>
        <div class="con_right">
            

                      
 <div class="Bread">
    	您目前的位置：<a href="http://sps.bjmu.edu.cn/" target="_blank;">院首页</a>><a href=../../index.htm>首页</a>
                > <a href=#>特聘研究员</a>
</div>            <div class="pageArticle">
                <div class="articleTitle">
                    <h2>刘合力</h2>
                    <h3>博士研究生导师</h3>
                </div>
                <div class="articleAuthor">
                    作者：&nbsp;&nbsp;来源：&nbsp;&nbsp;发布日期：2018年01月16日
                </div>
                <div class="article">
                    <p style="text-align: center">
	<img src="../../images/content/2015-12/20151226104930220844.jpg" style="height: 377px; width: 375px" /></p>
<p style="text-align: center">
	<span style="font-size: 18px"><strong>刘合力</strong></span></p>
<p align="center" style="text-align: center; line-height: 150%">
	&nbsp;</p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 18px"><strong><span style="background: #d9d9d9"><span style="font-family: 宋体">课题组</span></span></strong><strong><span style="background: #d9d9d9"><span style="font-family: times new roman">PI</span></span></strong><strong><span style="background: #d9d9d9"><span style="font-family: 宋体">简介</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 14px"><span style="color: #333333"><span style="font-family: 宋体">刘合力，北京大学医学部药学院研究员，博士生导师，国家自然基金优秀青年基金获得者</span></span><span style="color: #333333"><span style="font-family: 宋体">（</span></span><span style="color: #333333"><span style="font-family: times new roman">2013</span></span><span style="color: #333333"><span style="font-family: 宋体">），国家海外高层次人才计划</span></span><span style="color: #333333"><span style="font-family: times new roman">“</span></span><span style="color: #333333"><span style="font-family: 宋体">青年项目</span></span><span style="color: #333333"><span style="font-family: times new roman">”</span></span><span style="color: #333333"><span style="font-family: 宋体">获得者</span></span><span style="color: #333333"><span style="font-family: 宋体">（</span></span><span style="color: #333333"><span style="font-family: times new roman">2012</span></span><span style="color: #333333"><span style="font-family: 宋体">），北京大学优秀青年人才</span></span><span style="color: #333333"><span style="font-family: times new roman">“</span></span><span style="color: #333333"><span style="font-family: 宋体">百人计划</span></span><span style="color: #333333"><span style="font-family: times new roman">”</span></span><span style="color: #333333"><span style="font-family: 宋体">入选者（</span></span><span style="color: #333333"><span style="font-family: times new roman">2011</span></span><span style="color: #333333"><span style="font-family: 宋体">）；美国西北大学</span></span><span style="color: #333333"><span style="font-family: times new roman">Feinberg</span></span><span style="color: #333333"><span style="font-family: 宋体">医学院分子药理学与生物化学系，博士后、</span></span><span style="color: #333333"><span style="font-family: times new roman">Research associate (2006~2011</span></span><span style="color: #333333"><span style="font-family: 宋体">）；中国科学院生物物理研究所，生物化学与分子生物学博士</span></span><span style="color: #333333"><span style="font-family: times new roman">(2005</span></span><span style="color: #333333"><span style="font-family: 宋体">）；</span></span><span style="color: #333333"><span style="font-family: times new roman">Elsevier </span></span><span style="color: #333333"><span style="font-family: 宋体">期刊</span></span><em><span style="color: #333333"><span style="font-family: times new roman">Current Research in Pharmacology and Drug Discovery</span></span></em><span style="color: #333333"><span style="font-family: 宋体">和《中国药学》英文版的编委会成员。长期致力于细胞表面受体的信号转导结构机制和靶向药物研究。以第一作者或者通讯作者身份在</span></span><em><span style="color: #333333"><span style="font-family: times new roman">Cell</span></span></em><span style="color: #333333"><span style="font-family: 宋体">、</span></span><em><span style="color: #333333"><span style="font-family: times new roman">Nature Communications</span></span></em><span style="color: #333333"><span style="font-family: 宋体">、</span></span><em><span style="color: #333333"><span style="font-family: times new roman">PNAS</span></span></em><span style="color: #333333"><span style="font-family: 宋体">、</span></span><em><span style="color: #333333"><span style="font-family: times new roman">EMBO. J</span></span></em><span style="color: #333333"><span style="font-family: 宋体">、</span></span><span style="font-family: times new roman"><em><span style="color: #333333">J Autoimmun</span></em></span><span style="color: #333333">.</span><span style="color: #333333"><span style="font-family: 宋体">、</span></span><em><span style="color: #333333"><span style="font-family: times new roman">JBC</span></span></em><em><span style="color: #333333"><span style="font-family: 宋体">、</span></span></em><span style="font-family: times new roman"><em><span style="color: #333333">FEBS letters</span></em></span><span style="color: #333333"><span style="font-family: 宋体">等期刊发表了多篇研究论文；受邀在</span></span><em><span style="color: #333333"><span style="font-family: times new roman">Current Opinion in Structural Biology</span></span></em><span style="color: #333333"><span style="font-family: 宋体">上发表综述</span></span><span style="color: #333333"><span style="font-family: times new roman">1</span></span><span style="color: #333333"><span style="font-family: 宋体">篇；申请蛋白质类候选药物的国家发明专利</span></span><span style="color: #333333"><span style="font-family: times new roman">2</span></span><span style="color: #333333"><span style="font-family: 宋体">项（其中一项已经获得授权；另一项为选择性识别致癌突变</span></span><span style="color: #333333"><span style="font-family: times new roman">KIT ITD</span></span><span style="color: #333333"><span style="font-family: 宋体">的靶向单克隆抗体）；获得了国家海外高层次人才计划、国家自然基金优秀青年基金、</span></span><span style="color: #333333"><span style="font-family: times new roman">3</span></span><span style="color: #333333"><span style="font-family: 宋体">个国家自然基金面上项目和</span></span><span style="color: #333333"><span style="font-family: times new roman">1</span></span><span style="color: #333333"><span style="font-family: 宋体">个北京市自然基金面上项目等资助。</span></span></span></p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	&nbsp;</p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 18px"><strong><span style="background: #d9d9d9"><span style="font-family: 宋体">课题组网页</span></span></strong></span><span style="font-family: 宋体"><span style="font-size: 11pt">：</span></span><span style="font-size: 14px"><a href="http://222.28.103.88/labhome/"><span style="font-family: times new roman"><span style="color: #0000ff">http://222.28.103.88/labhome/</span></span></a><span style="font-family: 宋体">（限于北医校园网用户）</span></span></p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	&nbsp;</p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 18px"><strong><span style="background: #d9d9d9"><span style="font-family: 宋体">研究介绍</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: 宋体">细胞表面受体是全球</span><span style="font-family: times new roman">60%</span><span style="font-family: 宋体">药物的作用靶标，且蕴藏着癌症、神经精神类疾病等诸多重大疾病的药物靶标而亟待发现和确证。探讨潜在药物靶标的结构与功能关系，是精准调控它们功能的基础，是药物靶标确证不可或缺的重要步骤。本课题组将结构生物学技术与传统的药理学研究方法相结合，力图形成有自己特色的研究方向，即</span><span style="font-family: times new roman">“</span><span style="font-family: 宋体">细胞表面受体的分子和结构药理学研究</span><span style="font-family: times new roman">”</span><span style="font-family: 宋体">，旨在探讨细胞表面受体跨膜信号转导的结构机制、基于结构机制发现调节受体功能的分子工具（小分子化合物、单抗、蛋白质）、为癌症或自闭症等神经精神类疾病确证新的药物靶标，以此助力于原创性（</span><span style="font-family: times new roman">first-in-class</span><span style="font-family: 宋体">）</span><span style="font-family: times new roman">“</span><span style="font-family: 宋体">精准药物</span><span style="font-family: times new roman">”</span><span style="font-family: 宋体">的发现。</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: 宋体">我们先后着力于受体酪氨酸激酶（</span><span style="font-family: times new roman">receptor tyrosine kinases, RTKs</span><span style="font-family: 宋体">；如</span><span style="font-family: times new roman">KIT</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">CSF1R</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">PDGFR</span><span style="font-family: symbol">a</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">）、受体酪氨酸磷酸酶（</span><span style="font-family: times new roman">receptor-type protein tyrosine phosphatases, RPTPs</span><span style="font-family: 宋体">；如</span><span style="font-family: times new roman">PTP</span><span style="font-family: symbol">d</span><span style="font-family: 宋体">）、神经粘连受体（</span><span style="font-family: times new roman">CASPR2</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">ADAM22</span><span style="font-family: 宋体">、</span><span style="color: #212121"><span style="font-family: times new roman">neurexin</span></span><span style="color: #212121"><span style="font-family: 宋体">、</span></span><span style="font-family: times new roman">neurofascin</span><span style="font-family: 宋体">）、粘连型</span><span style="font-family: times new roman">G</span><span style="font-family: 宋体">蛋白偶联受体（</span><span style="font-family: times new roman">LPHN3</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">BAI3</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">FSHR</span><span style="font-family: 宋体">）、整合素</span><span style="font-family: 宋体">以及具有</span><span style="font-family: times new roman">GAP</span><span style="font-family: 宋体">（</span><span style="font-family: times new roman">GTPase</span><span style="font-family: 宋体">激活蛋白）活性的受体</span><span style="font-family: times new roman">Plexin</span><span style="font-family: 宋体">等的信号转导结构机制和靶标确证。<span style="color: black">近期的主要研究内容，简介如下：</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px"><strong><span style="color: #00b0f0"><span style="font-family: times new roman">1</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">、孤独症相关的信号复合体</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">SALM/LAR-RPTP</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">的信号转导机制和靶标确证</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="font-family: 宋体">孤独症相关的突触样黏附分子</span></span><span style="font-family: times new roman">-5</span><span style="font-family: 宋体">（</span><span style="font-family: times new roman">synaptic adhesion-like molecule 5</span><span style="font-family: 宋体">，</span><span style="font-family: times new roman">SALM5</span><span style="font-family: 宋体">）</span><span style="font-family: 宋体">位于神经突触后膜</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">可以结合位于突触前膜的白血球共同相关抗原受体酪氨酸磷酸酶</span><span style="font-family: 宋体">（</span><span style="font-family: times new roman">leukocyte common antigen-related receptor-type protein tyrosine phosphatases, LAR-RPTPs</span><span style="font-family: 宋体">，</span><span style="font-family: times new roman">LAR-RPTPs</span><span style="font-family: 宋体">）</span><span style="font-family: 宋体">家族成员从而诱导突触前膜分化</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">但两者互作的结构机制尚不清楚。我们用单对同晶置换兼反常散射法、分子置换法解析了</span><span style="font-family: times new roman">SALM5 LRR-Ig</span><span style="font-family: 宋体">结构域以及其与</span><span style="font-family: times new roman">LAR-RPTPs </span><span style="font-family: 宋体">家族成员</span><span style="font-family: times new roman">PTPδ</span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">Ig1-3</span><span style="font-family: 宋体">结构域（且小外显子</span><span style="font-family: times new roman">MeA</span><span style="font-family: 宋体">缺失）的复合物的晶体结构；通过结构指导的定点突变实验、</span><span style="font-family: times new roman">“</span><span style="font-family: 宋体">糖锲子（</span><span style="font-family: times new roman">glycan wedge</span><span style="font-family: 宋体">）</span><span style="font-family: times new roman">”</span><span style="font-family: 宋体">引入策略、</span><span style="font-family: times new roman">pulldown</span><span style="font-family: 宋体">、化学交联、表面等离子体共振、蛋白</span><span style="font-family: times new roman">-</span><span style="font-family: 宋体">细胞免疫荧光、超速离心分析、海马神经元突触形成等实验，证明了</span><span style="font-family: times new roman">SALM5</span><span style="font-family: 宋体">的二聚化是其发挥介导突触前膜分化功能的前提，</span><span style="font-family: 宋体">发现</span><span style="font-family: times new roman">SALM5</span><span style="font-family: 宋体">通过与受体酪氨酸磷酸酶</span><span style="font-family: times new roman">LAR-RPTP</span><span style="font-family: 宋体">反式互作形成独特的</span><span style="font-family: times new roman">2</span><span style="font-family: 宋体">：</span><span style="font-family: times new roman">2</span><span style="font-family: 宋体">的信号复合体结构而引起突触分化（图</span><span style="font-family: times new roman">1</span><span style="font-family: 宋体">），并指出</span><span style="font-family: times new roman">SALM5</span><span style="font-family: 宋体">的结合将调控</span><span style="font-family: times new roman">LAR-RPTP</span><span style="font-family: 宋体">的磷酸酶活性（至于如何调控有待进一步研究）以及基于此结构机制筛选靶向药物的可能性</span><span style="font-family: 宋体">（</span><em>Nature Commun.</em>2018 Jan 18; 9(1):268<span style="font-family: 宋体">；</span><em>Current Opinion in Structural Biology</em>. 2019 Feb 8; 54:59-67<span style="font-family: 宋体">）</span><span style="font-family: 宋体">。</span></span></p>
<p style="text-align: center">
	<img alt="" src="../../images/content/2021-03/20210304171931245659.jpg" style="height: 449px; width: 600px" /></p>
<p align="center" style="layout-grid-mode: char; text-align: center; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	&nbsp;</p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">图1、突触后膜上的<span style="font-family: times new roman">SALM5</span>（绿色<span style="font-family: times new roman">/</span>天青色）诱导并激活突触前膜上的受体<span style="font-family: times new roman">PTPδ</span>（黄色<span style="font-family: times new roman">/</span>洋红色）二聚化的结构机制【<em>Nature Commun.</em>2018 Jan 18; 9(1):268】。</span></p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px"><strong><span style="color: #00b0f0"><span style="font-family: times new roman">2</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">、孤独症相关的神经粘连受体</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">CASPR2</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">识别自免疫抗体的结构基础</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="font-family: 宋体">作为</span></span><span style="font-family: times new roman">neurexin</span><span style="font-family: 宋体">超家族的成员之一，</span><span style="font-family: times new roman">CASPR2</span><span style="font-family: 宋体">曾被认为是控制神经发育的分子网络的中心。</span><span style="font-family: 宋体">编码</span><span style="font-family: times new roman">CASPR2</span><span style="font-family: 宋体">的基因</span><em><span style="font-family: times new roman">CNTNAP2</span></em><span style="font-family: 宋体">敲除的小鼠表现出孤独症样行为；</span><span style="font-family: times new roman">CASPR2</span><span style="font-family: 宋体">的自免疫抗体可能是一类孤独症或自身免疫类边缘性脑炎的致病源。我们解析了</span><span style="font-family: times new roman">CASRP2</span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">DISC</span><span style="font-family: 宋体">结构域近原子分辨率（</span><span style="font-family: times new roman">1.31</span><span style="font-family: 宋体">埃）的晶体结构，基于结构设计并重组表达了一系列突变体，与法国里昂第一大学合作，用抗</span><span style="font-family: times new roman">CASPR2</span><span style="font-family: 宋体">边缘性脑炎病人的脑脊液，通过</span><span style="font-family: times new roman">ELISA</span><span style="font-family: 宋体">实验，确定了该结构域的一个</span><span style="font-family: times new roman">loop-tip</span><span style="font-family: 宋体">表面是</span><span style="font-family: times new roman">CASRP2</span><span style="font-family: 宋体">识别自免疫抗体的关键区域（</span><em>J Autoimmun</em>. 2019 Jan; 96:168-177<span style="font-family: 宋体">）</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 14px"><span style="color: #00b0f0"><span style="font-family: times new roman">3</span></span><span style="color: #00b0f0"><span style="font-family: 宋体">、</span></span><strong><span style="color: #00b0f0"><span style="font-family: 宋体">肿瘤微环境的重要构成蛋白</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">periostin</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">同亲性粘连的结构机制</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="font-family: 宋体">作为细胞表面受体整合素（</span></span><span style="font-family: times new roman">integrin</span><span style="font-family: 宋体">）的潜在配体，</span><span style="font-family: times new roman">periostin</span><span style="font-family: 宋体">在肿瘤微环境中通过与其他蛋白互作或与自身同亲性粘连而扮演多重角色：可重塑肿瘤微环境，可提高肿瘤细胞的低氧生存能力和耐药性，是潜在的抗肿瘤药物靶点。但其结构与功能关系一直未知。我们获得了人源</span><span style="font-family: times new roman">periostin</span><span style="font-family: 宋体">以及</span><span style="font-family: times new roman">C60S</span><span style="font-family: 宋体">突变体的晶体结构，结合多角度光散射、同亲性粘连实验和质谱实验，首次从结构上确定了</span><span style="font-family: times new roman">periostin</span><span style="font-family: 宋体">的同亲性粘连受</span><span style="font-family: times new roman">EMI</span><span style="font-family: 宋体">结构域调控；并利用质谱结合晶体结构首次发现</span><span style="font-family: times new roman">Cys60</span><span style="font-family: 宋体">发生了半胱氨酸化修饰。相关成果发表在</span><em>FEBS Lett</em>. 2018 Jun; 592(11):1789-1803<span style="font-family: 宋体">，</span><span style="font-family: 宋体">并被该期刊选为</span><span style="font-family: times new roman">2018</span><span style="font-family: 宋体">年度亮点文章（</span><strong><span style="color: #00b0f0"><span style="font-family: times new roman">FEBS Letters Highlights 2018</span></span></strong><span style="font-family: 宋体">）。</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px"><span style="color: #00b0f0"><span style="font-family: times new roman">4</span></span><span style="color: #00b0f0"><span style="font-family: 宋体">、</span></span><strong><span style="color: #00b0f0"><span style="font-family: 宋体">受体酪氨酸激酶</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">CSF1R</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">的配体</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">IL-34</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">的蛋白质二硫键工程</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="font-family: 宋体">白介素</span></span><span style="font-family: times new roman">IL-34</span><span style="font-family: 宋体">是</span><span style="font-family: times new roman">CSF1R</span><span style="font-family: 宋体">的一个配体，可以选择性增强小胶质细胞的神经保护功能，从而减轻</span><span style="font-family: symbol">b</span><span style="font-family: times new roman">-amyloid</span><span style="font-family: 宋体">的神经毒性，有望被开发成治疗</span><span style="font-family: times new roman">AD</span><span style="font-family: 宋体">的蛋白质药物。</span><span style="font-family: 宋体">对于蛋白类药物，保质期以及在体内的半衰期是决定成药性的重要条件，而这些条件与蛋白的热稳定性有关系。我们曾</span><span style="font-family: 宋体">解析了白介素</span><span style="font-family: times new roman">IL-34</span><span style="font-family: 宋体">的晶体结构</span><span style="font-family: 宋体">，揭示了</span><span style="font-family: times new roman">IL-34/CSF1R</span><span style="font-family: 宋体">识别的结构机制，并发现</span><span style="font-family: times new roman">IL-34</span><span style="font-family: 宋体">的内部分别位于两个</span><span style="font-family: symbol">a</span><span style="font-family: times new roman">-</span><span style="font-family: 宋体">螺旋的残基</span><span style="font-family: times new roman">Ser98</span><span style="font-family: 宋体">和</span><span style="font-family: times new roman">Cys168</span><span style="font-family: 宋体">的侧链之间形成弱氢键</span><span style="font-family: 宋体">（</span><em>Biochim Biophys Acta</em>. 2012 1824(7):938-45)<span style="font-family: 宋体">。鉴于此，我们将人源</span><span style="font-family: times new roman">IL-34</span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">Ser98</span><span style="font-family: 宋体">突变成</span><span style="font-family: times new roman">Cys</span><span style="font-family: 宋体">，用同步辐射圆二色谱实验证实突变体比野生型</span><span style="font-family: times new roman">IL</span><span style="font-family: 宋体">的变性温度提高了</span><span style="font-family: times new roman">7.6</span><span style="font-family: symbol">°</span><span style="font-family: times new roman">C</span><span style="font-family: 宋体">；用晶体结构证实突变体与野生型</span><span style="font-family: times new roman">IL-34</span><span style="font-family: 宋体">的总体结构高度相似，且激活</span><span style="font-family: times new roman">CSF-1R</span><span style="font-family: 宋体">自磷酸化及诱导细胞增殖的能力无明显差异。本</span><span style="font-family: 宋体">发明已经获得国家发明专利授权（</span><span style="color: black"><span style="font-family: times new roman">ZL2016102555350.1</span></span><span style="font-family: 宋体">）。</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px"><strong><span style="color: #00b0f0"><span style="font-family: times new roman">5</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">、</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">非典型性受体酪氨酸激酶</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">ROR2</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">的靶标确证</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">属于非典型性受体酪氨酸激酶（</span><span style="font-family: times new roman">RTK</span><span style="font-family: 宋体">），多数学者认为其并不像经典的</span><span style="font-family: times new roman">RTK</span><span style="font-family: 宋体">那样具有酪氨酸激酶活性。</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">在正常组织中低表达甚至不表达，而在黑色素瘤等肿瘤中高表达；且</span><span style="font-family: times new roman">Wnt5A-ROR2</span><span style="font-family: 宋体">信号轴对肿瘤进展十分重要。为此，</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">是潜在的抗肿瘤药物靶点，但亟待确证。基于</span><span style="font-family: times new roman">Wnt5A-ROR2</span><span style="font-family: 宋体">信号转导的结构机制，发现破坏</span><span style="font-family: times new roman">Wnt5A-ROR2</span><span style="font-family: 宋体">相互作用且抑制</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">信号的分子工具（蛋白质或单抗），是我们实现</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">靶标确证的基本策略。</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="font-family: 宋体">一方面，我们利用室内</span></span><span style="font-family: times new roman">X</span><span style="font-family: 宋体">光源上硫原子的单波长反常信号测定了</span><span style="font-family: times new roman">Wnt5A</span><span style="font-family: 宋体">拮抗蛋白家族</span><span style="font-family: times new roman">sFRPs</span><span style="font-family: 宋体">（</span><span style="font-family: times new roman">secreted Frizzled-related proteins</span><span style="font-family: 宋体">）</span><span style="font-family: 宋体">成员</span><span style="font-family: times new roman">sizzled</span><span style="font-family: 宋体">的晶体结构，并利用双荧光实验证实该家族蛋白的</span><span style="font-family: times new roman">CRD</span><span style="font-family: 宋体">结构域是捕获</span><span style="font-family: times new roman">Wnt</span><span style="font-family: 宋体">蛋白的分子工具（图</span><span style="font-family: times new roman">2</span><span style="font-family: 宋体">）（</span><em>J Biol Chem.</em>2017 Sep 29; 292(39):16055-16069<span style="font-family: 宋体">）。</span></span></p>
<p style="text-align: center">
	<span style="font-size: 14px"><img alt="" src="../../images/content/2021-03/20210304172038277726.jpg" style="height: 600px; width: 600px" />&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">图2、S<span style="font-family: times new roman">izzled</span>的结构和功能关系。（<span style="font-family: times new roman">1</span>）非洲爪蟾<span style="font-family: times new roman">Sizzled</span>的晶体；（<span style="font-family: times new roman">2</span>）利用单波长反常散射法找到三个硫原子，并以此计算相位合成的电子密度图可见<span style="font-family: times new roman">Sizzled</span>含有两个相对独立的结构域；（<span style="font-family: times new roman">3</span>）结构分析表明其<span style="font-family: times new roman">NTR</span>结构域具有新的折叠模式；（<span style="font-family: times new roman">4</span>）<span style="font-family: times new roman">A</span>、比较<span style="font-family: times new roman">Sizzled</span>全长结构（<span style="font-family: times new roman">CRD</span>结构域，天青色；<span style="font-family: times new roman">NTR</span>结构域，浅棕色；<span style="font-family: times new roman">PAM</span>，棕榈酰基团，红色）与<span style="font-family: times new roman">mFrizzled-XWnt8</span>复合物结构（<span style="font-family: times new roman">mFrizzled</span>的<span style="font-family: times new roman">CRD</span>结构域，绿色；<span style="font-family: times new roman">XWnt8</span>，粉色）；<span style="font-family: times new roman">B</span>、两结构在<span style="font-family: times new roman">XWnt8 index finger</span>区域的差异细节；<span style="font-family: times new roman">C</span>、两结构在<span style="font-family: times new roman">XWnt8 thumb</span>区域的差异细节；（<span style="font-family: times new roman">5</span>）<span style="font-family: times new roman">Sizzled</span>以及突变体<span style="font-family: times new roman">Sizzled CRD C115S</span>、<span style="font-family: times new roman">Sizzled CRD C115S/H116Y/H118F</span>的分子筛色谱图以及<span style="font-family: times new roman">SDS-PAGE</span>结果；（<span style="font-family: times new roman">6</span>）在<span style="font-family: times new roman">Wnt3a</span>引发<span style="font-family: times new roman">HEK293</span>细胞的双荧光实验中，相较于野生型<span style="font-family: times new roman">Sizzled</span>，其突变体可显著地拮抗<span style="font-family: times new roman">Wnt3a</span>信号。</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: 宋体">另一方面</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">我们利用</span><span style="font-family: times new roman">siRNA</span><span style="font-family: 宋体">或慢病毒递送</span><span style="font-family: times new roman">shRNA</span><span style="font-family: 宋体">进行</span><span style="font-family: times new roman">“</span><span style="font-family: 宋体">功能失去性</span><span style="font-family: times new roman">”</span><span style="font-family: 宋体">（</span><span style="font-family: times new roman">loss-of-function</span><span style="font-family: 宋体">）</span><span style="font-family: 宋体">实验，证实</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">对肿瘤细胞增殖、侵润和迁移的作用</span><span style="font-family: 宋体">；</span><span style="font-family: 宋体">利用杂交瘤技术获得了</span><span style="font-family: times new roman">22</span><span style="font-family: 宋体">株抗</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">的单克隆抗体</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">并发现</span><span style="font-family: times new roman">8H6</span><span style="font-family: 宋体">等</span><span style="font-family: 宋体">单抗能抑制</span><span style="font-family: times new roman">Wnt5A-ROR2</span><span style="font-family: 宋体">信号介导的肿瘤转移</span><span style="font-family: 宋体">；利用生物化学或结构生物学技术，我们发现这些抗体作用于</span><span style="font-family: times new roman">ROR2</span><span style="font-family: 宋体">的特定结构域而发挥功能。</span></span></p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px"><strong><span style="color: #00b0f0"><span style="font-family: times new roman">6</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">、基于结构机制的受体酪氨酸激酶</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: times new roman">KIT</span></span></strong><strong><span style="color: #00b0f0"><span style="font-family: 宋体">突变体的靶标确证</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: 宋体">受体酪氨酸激酶（</span><span style="font-family: times new roman">RTK</span><span style="font-family: 宋体">）是药物可及性（</span><span style="font-family: times new roman">druggability</span><span style="font-family: 宋体">）最高的细胞表面受体家族，其致癌性突变备受关注，但多数研究是以小分子抑制剂为干预手段针对</span><span style="font-family: times new roman">RTK </span><span style="font-family: 宋体">的胞内激酶结构域。第三类</span><span style="font-family: times new roman">RTK </span><span style="font-family: 宋体">胞外区的致癌性突变主要集中在第</span><span style="font-family: times new roman">5 </span><span style="font-family: 宋体">个</span><span style="font-family: times new roman">Ig </span><span style="font-family: 宋体">样结构域，而</span><span style="font-family: times new roman">KIT </span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">A502</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">Y503 </span><span style="font-family: 宋体">的内部重复串联（</span><span style="font-family: times new roman">internal tandem duplication</span><span style="font-family: 宋体">，</span><span style="font-family: times new roman">ITD</span><span style="font-family: 宋体">）突变（下称</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">）为其中最有代表性的致癌性突变。</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">突变体</span><span style="font-family: 宋体">在</span><span style="font-family: times new roman">10%</span><span style="font-family: 宋体">的胃肠道间质瘤中高表达，与病人预后差和</span><span style="font-family: times new roman">KIT</span><span style="font-family: 宋体">靶向药物伊买替尼的耐药性密切相关；但该突变体是否可以成为药物靶标尚不清楚。</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="font-family: 宋体">我们曾较为深入地研究过第三类</span></span><span style="font-family: times new roman">RTK</span><span style="font-family: 宋体">受体的信号转导机制【</span><span style="font-family: times new roman">KIT/SCF</span><span style="font-family: 宋体">（</span><strong>Liu</strong>&amp; Chen et al., <em>EMBO J</em>. 2007 26(3):891-901<span style="font-family: 宋体">）</span><span style="font-family: times new roman">, PDGF</span><span style="font-family: symbol">b</span><span style="font-family: times new roman">/PDGFR</span><span style="font-family: symbol">b</span><span style="font-family: times new roman">(An &amp; <strong>Liu</strong> et al., <em>PNAS</em> 2010 107(25):11307-12), CSF1/FMS (Chen et al., <em>PNAS</em>, 2008 105(47):18267-72) </span><span style="font-family: 宋体">以及</span><span style="font-family: times new roman">IL34/FMS (<strong>Liu</strong> et al., <em>Biochim Biophys Acta</em>. 2012 1824(7):938-45)</span><span style="font-family: 宋体">】</span><span style="font-family: 宋体">，并基于信号转导的结构机制，设计合适的</span><span style="font-family: 宋体">抗原免疫小鼠</span><span style="font-family: 宋体">以及合适的突变体用于</span><span style="font-family: times new roman">ELISA</span><span style="font-family: 宋体">筛选，</span><span style="font-family: 宋体">利用传统的杂交瘤技术获得了包括</span><span style="font-family: times new roman">3G2</span><span style="font-family: 宋体">在内的</span><span style="font-family: times new roman">7</span><span style="font-family: 宋体">株可以选择性识别</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">的单克隆抗体。</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: 宋体">对于</span><span style="font-family: times new roman">3G2</span><span style="font-family: 宋体">单抗</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">我们利用表面等离子体技术测定出其与</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">的亲和力高于与</span><span style="font-family: times new roman">KIT WT</span><span style="font-family: 宋体">（</span><span style="font-family: 宋体">野生型</span><span style="font-family: 宋体">）</span><span style="font-family: 宋体">的</span><span style="font-family: 宋体">（</span><span style="font-family: 宋体">近</span><span style="font-family: times new roman">10</span><span style="font-family: 宋体">倍</span><span style="font-family: 宋体">）；</span><span style="font-family: 宋体">采用流式细胞术实验证实了</span><span style="font-family: times new roman">3G2 </span><span style="font-family: 宋体">抗体可差异性地识别稳定表达</span><span style="font-family: times new roman">KIT WT </span><span style="font-family: 宋体">及</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">Ba/F3 </span><span style="font-family: 宋体">细胞</span><span style="font-family: 宋体">；</span><span style="font-family: 宋体">发现</span><span style="font-family: times new roman">3G2 </span><span style="font-family: 宋体">抗体能有效抑制离体的稳定表达</span><span style="font-family: times new roman">KIT ITD </span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">Ba/F3 </span><span style="font-family: 宋体">的细胞</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">其</span><span style="font-family: times new roman">IC<sub>50</sub> </span><span style="font-family: 宋体">为</span><span style="font-family: times new roman">1.29 nM</span><span style="font-family: 宋体">；</span><span style="font-family: 宋体">通过</span><span style="font-family: times new roman">BALB/c </span><span style="font-family: 宋体">鼠荷瘤实验</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">我们发现</span><span style="font-family: times new roman">3G2 </span><span style="font-family: 宋体">抗体可以抑制稳定表达</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">Ba/F3 </span><span style="font-family: 宋体">肿瘤的生长</span><span style="font-family: 宋体">；</span><span style="font-family: 宋体">利用同步辐射光源测定了</span><span style="font-family: times new roman">3G2 Fab/KIT ITD </span><span style="font-family: 宋体">复合物的晶体结构</span><span style="font-family: 宋体">，</span><span style="font-family: 宋体">阐明了</span><span style="font-family: times new roman">3G2</span><span style="font-family: 宋体">抗体选择性识别</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">的结构基础</span><span style="font-family: 宋体">（</span><span style="font-family: 宋体">图</span><span style="font-family: times new roman">3</span><span style="font-family: 宋体">）</span><span style="font-family: 宋体">。其次，我们初步探讨了</span><span style="font-family: times new roman">3G2 </span><span style="font-family: 宋体">抗体的作用机制，并发现</span><span style="font-family: times new roman">3G2 </span><span style="font-family: 宋体">抗体可以抑制</span><span style="font-family: times new roman">KIT</span><span style="font-family: 宋体">下游信号分子</span><span style="font-family: times new roman">ERK</span><span style="font-family: 宋体">、</span><span style="font-family: times new roman">AKT </span><span style="font-family: 宋体">及</span><span style="font-family: times new roman">S6</span><span style="font-family: 宋体">分子的磷酸化水平，可促使</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">分子的内化，并导致</span><span style="font-family: times new roman">KIT ITD</span><span style="font-family: 宋体">的</span><span style="font-family: times new roman">Ba/F3</span><span style="font-family: 宋体">细胞的程序性凋亡。</span></span></p>
<p style="text-align: center">
	<span style="font-size: 14px"><img alt="" src="../../images/content/2021-03/20210304172108871822.jpg" style="height: 302px; width: 700px" />&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">图3、<span style="background: white"><span style="color: black">3G2</span></span><span style="background: white"><span style="color: black">抗体抑制小鼠体内</span></span><span style="background: white"><span style="color: black">Ba/F3 KIT ITD</span></span><span style="background: white"><span style="color: black">肿瘤生长及与抗原的复合物结构。</span></span><span style="background: white"><span style="color: black">(a-b) Ba/F3-KIT ITD<sup>502-503</sup></span></span><span style="background: white"><span style="color: black">异种移植小鼠在分别给予</span></span><span style="background: white"><span style="color: black">2 mg/kg</span></span><span style="background: white"><span style="color: black">、</span></span><span style="background: white"><span style="color: black">4 mg/kg</span></span><span style="background: white"><span style="color: black">的</span></span><span style="background: white"><span style="color: black">3G2</span></span><span style="background: white"><span style="color: black">抗体及</span></span><span style="background: white"><span style="color: black">4 mg/kg</span></span><span style="background: white"><span style="color: black">的</span></span><span style="background: white"><span style="color: black">IgG</span></span><span style="background: white"><span style="color: black">（对照组）后测量的体重</span></span><span style="background: white"><span style="color: black">(a)</span></span><span style="background: white"><span style="color: black">和肿瘤尺寸</span></span><span style="background: white"><span style="color: black">(b)</span></span><span style="background: white"><span style="color: black">；初始体重设为</span></span><span style="background: white"><span style="color: black">100%</span></span><span style="background: white"><span style="color: black">。</span></span><span style="background: white"><span style="color: black">(c-d) </span></span><span style="background: white"><span style="color: black">在第</span></span><span style="background: white"><span style="color: black">17</span></span><span style="background: white"><span style="color: black">天处死小鼠后所取肿瘤的照片</span></span><span style="background: white"><span style="color: black">(c)</span></span><span style="background: white"><span style="color: black">和瘤体重量</span></span><span style="background: white"><span style="color: black">(d)</span></span><span style="background: white"><span style="color: black">。比例尺：</span></span><span style="background: white"><span style="color: black">1cm</span></span><span style="background: white"><span style="color: black">。对于</span></span><span style="background: white"><span style="color: black">(a)</span></span><span style="background: white"><span style="color: black">、</span></span><span style="background: white"><span style="color: black">(b)</span></span><span style="background: white"><span style="color: black">及</span></span><span style="background: white"><span style="color: black">(e)</span></span><span style="background: white"><span style="color: black">所展示数据为平均值</span></span><span style="background: white"><span style="color: black">±</span></span><span style="background: white"><span style="color: black">均值标准误差（以误差线表示）。用</span></span><span style="background: white"><span style="color: black">Microsoft Excel</span></span><span style="background: white"><span style="color: black">软件的双尾</span></span><span style="background: white"><span style="color: black">Student’s t test</span></span><span style="background: white"><span style="color: black">计算</span></span><span style="background: white"><span style="color: black">p</span></span><span style="background: white"><span style="color: black">值；</span></span><span style="background: white"><span style="color: black">***p &lt; 0.001</span></span><span style="background: white"><span style="color: black">，</span></span><span style="background: white"><span style="color: black">**p &lt; 0.01</span></span><span style="background: white"><span style="color: black">，</span></span><span style="background: white"><span style="color: black">*p &lt; 0.05</span></span><span style="background: white"><span style="color: black">。（</span></span><span style="background: white"><span style="color: black">e</span></span><span style="background: white"><span style="color: black">）</span></span><span style="background: white"><span style="color: black">KIT D4-D5 ITD</span></span><span style="background: white"><span style="color: black">与</span></span><span style="background: white"><span style="color: black">3G2 Fab</span></span><span style="background: white"><span style="color: black">复合物结构的飘带模式图；（</span></span><span style="background: white"><span style="color: black">f</span></span><span style="background: white"><span style="color: black">）</span></span><span style="background: white"><span style="color: black">KIT ITD</span></span><span style="background: white"><span style="color: black">突变区与</span></span><span style="background: white"><span style="color: black">3G2</span></span><span style="background: white"><span style="color: black">互作的界面，参与相互作用的氨基酸以棍棒模式展示，氢键以虚线展示；颜色代码：</span></span><span style="background: white"><span style="color: black">KIT D4-D5 ITD</span></span><span style="background: white"><span style="color: black">，天青色；</span></span><span style="background: white"><span style="color: black">3G2</span></span><span style="background: white"><span style="color: black">重链，紫色；</span></span><span style="background: white"><span style="color: black">3G2</span></span><span style="background: white"><span style="color: black">轻链，黄色。</span></span></span></p>
<p style="layout-grid-mode: char; margin: 3.1pt 0cm; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="background: white; layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 18px"><span style="font-family: times new roman"><strong><span style="background: #d9d9d9"><span style="font-family: 宋体">代表性成果</span></span></strong></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">1.&nbsp;&nbsp;&nbsp; <strong>Liu H</strong>*. Synaptic organizers: synaptic adhesion-like molecules (SALMs). <strong><em>Current Opinion in Structural Biology</em></strong>. 2019 Feb 8; 54:59-67. (Invited review) (hereinafter *corresponding author)</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">2.&nbsp;&nbsp;&nbsp; Liang W#, Zhang J#, Saint-Martin M#, Xu F, Noraz N, Liu J, Honnorat J*, <strong>Liu H</strong>*. Structural mapping of hot spots within human CASPR2 discoidin domain for autoantibody recognition.<strong><em>J Autoimmun</em></strong>. 2019 Jan; 96:168-177 (#equal contribution)</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="color: black">3.&nbsp;&nbsp;&nbsp; Liu J, Zhang J, Xu F, Lin Z, Li Z, <strong>Liu H</strong>*. Structural characterizations of human periostin dimerization and cysteinylation. <strong><em>FEBS Lett.</em></strong> 2018 Jun; 592(11):1789-1803 (</span></span><strong><span style="color: black">FEBS Letters Highlights 2018</span></strong><span style="color: black">)</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">4.&nbsp;&nbsp;&nbsp; Lin Z, Liu J, Ding H, Xu F, <strong>Liu H</strong>*. Structural basis of SALM5-induced PTPδ dimerization for synaptic differentiation. <strong><em>Nature Commun</em>.</strong> 2018 Jan 18; 9(1):268</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">5.&nbsp;&nbsp;&nbsp; Bu Q, Li Z, Zhang J, Xu F, Liu J, <strong>Liu H</strong>*. The crystal structure of full-length Sizzled from Xenopus laevis yields insights into Wnt-antagonistic function of secreted Frizzled-related proteins. <strong><em>J Biol Chem</em>.</strong> 2017 Sep 29; 292(39):16055-16069</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">6.&nbsp;&nbsp;&nbsp; Jiang X*, Fischer D, Chen X, McKenna SD, <strong>Liu H</strong>, Sriraman V, Yu HN, Goutopoulos A, Arkinstall S, He X. Evidence for follicle-stimulating hormone receptor as a functional trimer. <strong><em>J Biol Chem</em></strong>. 2014 May 16;289(20):14273-82</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">7.&nbsp;&nbsp;&nbsp; Jiang X*, <strong>Liu H</strong>, Chen X, Chen PH, Fischer D, Sriraman V, Yu HN, Arkinstall S, He X. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. <strong><em>Proc Natl Acad Sci U S A</em></strong>. 2012 Jul 31; 109(31):12491-6</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">8.&nbsp;&nbsp;&nbsp; <strong>Liu H</strong>, Leo C, Chen X, Wong BR, Williams LT, Lin H, He X*. The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. <strong><em>Biochim Biophys Acta</em></strong>. 2012 Jul; 1824(7):938-45</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">9.&nbsp;&nbsp;&nbsp; <strong>Liu H</strong>, Focia PJ, He X*. Homophilic adhesion mechanism of neurofascin, a member of the L1 family of neural cell adhesion molecules, <strong><em>Journal of Biological Chemistry</em></strong>, 2011.1.7, 286(1): 797-805</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">10. <strong>Liu H</strong>, Juo ZS, Shim AH, Focia PJ, Chen X, Garcia KC, He X*. Structural basis of Semaphorin-Plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1. <strong><em>Cell</em></strong>. 2010 Sep 3; 142(5):749-61 (<strong>Commented by F1000)</strong></span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">11. Shim AH#, <strong>Liu H</strong>#, Chen X, Lin PC, He X*. Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex. <strong><em>Proc Natl Acad Sci U S A</em></strong>. 2010 Jun 22; 107(25): 11307-12 (#equal contribution)</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">12<strong>. Liu H</strong>, Shim AH, He X<sup>*</sup>. Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: INSIGHTS ON ADAM FUNCTION, <strong><em>Journal of Biological Chemistry</em></strong>, 2009.10.16, 284(42): 29077-29086 (<strong>selected as <em>Papers of the Week</em></strong><em>)</em></span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="color: black">13. Chen X, <strong>Liu H</strong>, Focia PJ, Shim AH, He X. </span></span>Structure of macrophage colony stimulating factor bound to FMS: diverse signaling assemblies of class III receptor tyrosine kinases.<span style="color: black"><strong><em>Proc Natl Acad Sci U S A.</em></strong> 2008 Nov 25;105(47):18267-72</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><span style="color: black">14. </span></span><span style="color: black">Chen X,<strong>Liu H</strong>, Shim AH, Focia PJ, He X.Chen X, et al. Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions. <strong><em>Nature Struct Mol Biol</em></strong>. 2008 Jan;15(1):50-6.</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.45pt; line-height: 18pt; text-indent: -21.3pt">
	<span style="font-size: 14px"><span style="font-family: times new roman"><strong><span style="color: black">15. Liu H</span></strong></span><sup><span style="color: black">#</span></sup><span style="color: black">, Chen X<sup>#</sup>, Focia PJ, He X<sup>*</sup>. Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases, <strong><em>The EMBO Journal</em></strong>, 2007.2.7, 26(3): 891-901 (<sup>#</sup>equal contribution)</span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">16.&nbsp; </span></span><strong><span style="color: black"><span style="font-family: 宋体">刘合力</span></span></strong><span style="color: black"><span style="font-family: 宋体">、<strong>黄国龙</strong>等<strong>，</strong>一种提高白介素</span></span><span style="color: black"><span style="font-family: times new roman">IL-34</span></span><span style="color: black"><span style="font-family: 宋体">热力学稳定性的方法，中国发明专利授权号</span></span><span style="color: black"><span style="font-family: times new roman">ZL2016102555350.1</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt 35.4pt; line-height: 18pt; text-indent: -21.25pt">
	<span style="font-size: 14px"><span style="color: black"><span style="font-family: times new roman">17.&nbsp; </span></span><strong><span style="color: black"><span style="font-family: 宋体">刘合力、丁焕弟</span></span></strong><span style="color: black"><span style="font-family: 宋体">等</span></span><span style="color: black"><span style="font-family: times new roman">, </span></span><span style="color: black"><span style="font-family: 宋体">一种选择性识别</span></span><span style="color: black"><span style="font-family: times new roman">KIT ITD</span></span><span style="color: black"><span style="font-family: 宋体">致癌性突变的单克隆抗体及其应用，中国发明专利申请号</span></span><span style="color: black"><span style="font-family: times new roman">201810588853.X</span></span></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 14px">&nbsp;</span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt; line-height: 18pt">
	<span style="font-size: 18px"><strong><span style="background: #d9d9d9"><span style="font-family: 宋体">招聘招生</span></span></strong></span></p>
<p style="layout-grid-mode: char; text-align: justify; margin: 3.1pt 0cm 0pt; line-height: 18pt; text-indent: 24pt">
	<span style="font-size: 14px"><span style="font-family: times new roman">1</span><span style="font-family: 宋体">、博士后：欢迎神经</span><span style="font-family: times new roman">/</span><span style="font-family: 宋体">肿瘤生物学或药理学、低温电镜结构生物学的博士（毕业</span><span style="font-family: times new roman">0-5</span><span style="font-family: 宋体">年）来合作开展高水平研究，待遇从优。</span><span style="font-family: times new roman">2</span><span style="font-family: 宋体">、招生：欢迎有志于在结构水平研究生物医学规律或追求原创性药物发现的研究生、本科生来学习。</span>&nbsp;&nbsp;&nbsp;</span></p>

                </div>
                    </div>
        </div>
    </div>
    
    
</div>

<div class="footer">
  <div class="footer_con">
    <div class="lf">
        <ul>
                <li><a href="http://www.who.int/en/">世界卫生组织</a></li>
        	        <li><a href="http://www.most.gov.cn/">中华人民共和国科学技术部</a></li>
        	        <li><a href="http://www.moe.edu.cn/">中华人民共和国教育部</a></li>
        	        <li><a href="http://www.cams.ac.cn/">中国医学科学院</a></li>
        	        <li><a href="http://www.pku.edu.cn/">北京大学</a></li>
        	
        </ul>
        <ul>
                            <li><a href="http://sps.bjmu.edu.cn/">北京大学药学院</a></li>
                  	                  <li><a href="http://www.nsfc.gov.cn/">国家自然基金委员会</a></li>
                  	                  <li><a href="http://www.cnphars.org/">中国药理学会</a></li>
                  	                  <li><a href="http://www.sda.gov.cn/">国家食品药品监督管理局</a></li>
                  	                  <li><a href="http://www.satcm.gov.cn/web2010/">国家中医药管理局</a></li>
                  	        </ul>
    </div>
    <div class="rt">
                                                             <div class="code2d"><img src="../../images/content/2018-01/20180116100032324995.png"></div>
                            
     
    </div>
  </div>
    <div class="copyRight">
        版权所有：北京大学药学院      地址：北京市海淀区学院路38号 邮编：100191    电话: 010-82805656;010-82802184    E-mail：yxdb@bjmu.edu.cn
    </div>
</div><script type="text/javascript" src="../../js/js201801/jquery-1.9.0.min.js"></script>
<script type="text/javascript" src="../../js/js201801/script.js"></script>
<script type="text/javascript">
    Nav('#nav');  

</script>

</body></html>